HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Roy F Riascos Selected Research

Roy F Riascos Research Topics

Disease

3Ischemic Stroke
01/2022 - 10/2019
3Infarction (Infarctions)
01/2022 - 10/2019
3Neoplasms (Cancer)
01/2021 - 10/2013
2Glioma (Gliomas)
09/2022 - 01/2018
2Stroke (Strokes)
01/2021 - 01/2020
1Brain Ischemia (Cerebral Ischemia)
01/2022
1Cerebral Infarction
01/2021
1Papilledema
01/2020
1Intracranial Hemorrhages (Intracranial Hemorrhage)
01/2020
1Refractive Errors (Refractive Error)
01/2020
1Vasculitis (Vasculitides)
10/2019
1CADASIL
10/2019
1Neurofibroma
12/2018
1Opportunistic Infections (Opportunistic Infection)
10/2014

Drug/Important Bio-Agent (IBA)

2alpha-hydroxyglutarateIBA
09/2022 - 01/2018
2Biomarkers (Surrogate Marker)IBA
09/2022 - 01/2021
2Cytidine Triphosphate (CTP)IBA
01/2022 - 01/2020
1Circulating Tumor DNAIBA
01/2021
1Tissue Plasminogen Activator (Alteplase)FDA Link
01/2021
1Retinaldehyde (Retinal)IBA
01/2020
1Pharmaceutical PreparationsIBA
10/2019
1EverolimusFDA Link
12/2018
1Choline (Choline Chloride)IBA
01/2018
1Methionine (L-Methionine)FDA Link
01/2018
1Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA
01/2018
1Glycine (Aminoacetic Acid)FDA LinkGeneric
01/2018

Therapy/Procedure

2Thrombectomy
01/2022 - 01/2021
1Punctures
01/2021
1Therapeutics
10/2014
1Central Venous Catheters
10/2013
1Drug Therapy (Chemotherapy)
10/2013
1Radiotherapy
10/2013